Universitätsklinikum Düsseldorf
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 | 2026-10-01 | NCT06565195 | |
| Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function | Arterial Occlusive Diseases, Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Ventricular Dysfunction, Ventricular Dysfunction, Left, anterolateral myocardial infarction, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, inferior myocardial infarction, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-07-28 | NCT04763200 | |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Community-Acquired Infections, Community-Acquired Pneumonia, DNA Virus Infections, Disease Attributes, Healthcare-Associated Pneumonia, Herpesviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, Skin Diseases, Viral, Skin and Connective Tissue Diseases, herpes simplex infectious disease, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-07-23 | NCT06134492 | |
| Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) | Chronic Rhinosinusitis With Nasal Polyposis | Active, not recruiting | Not stated | 2026-07-13 | NCT04959448 | |
| Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer | cancer, neoplasm | Active, not recruiting | Phase 3 | 2026-07-07 | NCT04464226 | |
| Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-04-24 | NCT03155997 | |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-04-21 | NCT03188874 | |
| T-cell Therapy in Patients With PML | DNA Virus Infections, Encephalitis, Viral, Infections, Leukoencephalopathies, Neuroinflammatory Diseases, Slow Virus Diseases, brain disorder, central nervous system disorder, central nervous system infectious disorder, demyelinating disease, encephalitis, infectious encephalitis, nervous system disorder, polyomavirus infectious disease, progressive multifocal leukoencephalopathy, viral infection of central nervous system, viral infectious disease | Recruiting | Phase 2 | 2026-02-12 | NCT06990087 | |
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT05366218 | |
| Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2025-10-03 | NCT06765226 | |
| Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Leigh syndrome, Nutritional and Metabolic Diseases, Pyruvate Metabolism, Inborn Errors, brain disorder, central nervous system disorder, contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inborn mitochondrial metabolism disorder, metabolic disease, nervous system disorder | Recruiting | Not stated | 2025-05-13 | NCT06967831 |